Can insider trading charges derail political campaigns? Should you trust a fund manager over a doctor? And how many rats would you trade for a cow?

We discuss all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Tune in for a conversation about the charges against Rep. Chris Collins, who is accused of illegally tipping off his son that their big biotech investment was about to go belly-up. Then we delve into a contentious online dispute between Impossible Foods, which hopes to reduce animal suffering, and PETA, which hopes to reduce animal suffering. And we’ll explore an increasingly common question in biotech: When Wall Street says data are bad but doctors argue otherwise, what are you supposed to conclude? Finally we’ll embark upon a lightning round, covering the latest in drug-price finger-pointing and what you should call a unicorn that has outgrown its horn.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy